Cell viability of four colorectal cancer cell lines after 24 hr treatment with 0.1–1000 ng/ml of TRAIL was measured and compared to the viability of oxaliplatin-resistant (OxR) cell lines (Figure 1A). This evidence concerns the gene TNFSF10 and colorectal cancer.